ReviewCancers2026

Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence.

Cristian J Salazar-Vilches et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.